From 1 May 2023, the Pharmaceutical Benefits Scheme (PBS) item codes for donepezil, galantamine, memantine and rivastigmine, for the treatment of mild to moderately severe Alzheimer’s disease, will be updated to combine the ‘Initial 1’ and ‘Initial 2’ treatment phases.
The Queensland Rural Generalist Pathway (QRGP) is considering trialling a Rural Generalist Obstetric Clinical Training Support role for DRANZCOG Advanced trainees during their advanced skills training year.
Do you want to boost your telehealth clinical skills and provide better care to your patients? Then look no further than the ACRRM Telehealth Clinical Skills Program 2023, a unique and FREE opportunity designed specifically for clinicians in Australia.
The Australian Commission on Quality and Safety in Health Care (ACSQHC) has released a draft Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard for consultation.
The Department of Veterans’ Affairs (DVA) is seeking a College representative to join the DVA General Practitioner Advisory Group (GPAG) which will commence operations in June 2023.
The Therapeutic Goods Administration (TGA) has sent a reminder that the dual labelling period for most dual labelled medicines will end on Thursday 20 April 2023.
The College recognises that climate change can have a significant impact on the health and wellbeing of rural and remote communities, and a personal impact on our members and on rural practice more broadly.
The Australian Government has announced the addition of new claimable conditions to the Scheme based on advice from the Therapeutic Goods Administration (TGA). The changes to clinical conditions and vaccines accepted under the scheme can be claimed retrospectively in respect of eligible conditions arising from vaccines administered from the start of the vaccine roll-out on 22 February 2021.
The Australian College of Rural and Remote Medicine mourns the passing of Gumatj leader Yunupingu, a leader and defender of his Yolŋu people and for Aboriginal people throughout Australia.
Heart failure (HF) is common in Australia, with an estimated 61,000 individuals diagnosed annually. Only 20% of those hospitalised subsequently enrol in hospital-based disease management programs, with access especially limited in regional and remote communities.
The Department of Health and Aged Care has advised that the National Health (COVID-19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 which allows image-based prescribing in hospitals and signature exemptions for prescription record forms, will end on Friday 31 March 2023.
During the COVID-19 pandemic, local public health units (LPHUs) were established to manage local cases and outbreaks of COVID-19. Since July 2022, the nine LPHUs (3 metropolitan, 6 regional) have broadened their responsibilities to include disease prevention, population health, and investigation and response to notifiable conditions.
my health is an Australian Digital Health Agency (ADHA) owned and managed app, and is the latest digital tool developed by the Agency to help consumers and their carers engage with and be proactive in managing their health.
This month, the College submitted its feedback to Ahpra on its consultation regarding the proposed draft revised registration standard granting general registration to Australian and New Zealand medical graduates on completion of Internship.